Skip to content
Monday, March 8, 2021
Latest:
  • International Women’s Day: Interview with Dr. Meagan Pitcher
  • Common myths and truths about lymphedema
  • Pandemic, power outages, and…policy on child poverty?
  • Proteomics analysis identifies potential drug targets for aggressive human cancers
  • Resonance podcast: Clinical education and the art of ballroom dancing

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Connect With Us
  • bcm.edu

cancer therapy

From The Labs 

Proteomics analysis identifies potential drug targets for aggressive human cancers

March 4, 2021March 4, 2021 Ana Rodríguez 0 Comments agrressive cancer, cancer proteomics, cancer therapy, cancer transcriptomics, Research

Researchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.

Read more
From The Labs 

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021 Ana Rodríguez 0 Comments Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

Read more
From The Labs 

Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells

August 20, 2020August 20, 2020 Ana Rodríguez 0 Comments alloimmune defense receptor, cancer therapy, CAR T cells, Off-the-shelf therapeutic T cells, Research

Baylor College of Medicine researchers extend the life and effectiveness of off-the-shelf, cancer-fighting immune T cells.

Read more
From The Labs 

New insights into the mediators of patient recovery after CAR T cell immunotherapy

July 21, 2020July 28, 2020 Ana Rodríguez 0 Comments cancer therapy, CAR T cell, Clinical Trials, complete response, HER-2, Immunotherapy, Research, rhabdomyosarcoma

Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.

Read more
From The Labs 

From the labs to commercialization: Companies merge to implement Baylor College of Medicine-developed therapies for cancer

August 16, 2018August 16, 2018 Ana Rodríguez 0 Comments cancer therapy, commercialization, Marker Therapeutics, Research, T cells, TapImmune, tumor cells

Despite major advances in cancer therapy, conventional cancer treatments continue to be associated with devastating side effects for patients and are not always curative. In

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs features an image of the laboratory worm, Caenorhabditis elegans. Image credit: Dr. Tao Chen/Wang lab.

Healthy Habits: A DOC-umentary Series

https://youtu.be/MAXO08xs9fc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951